Selecting haematological malignancy patients for intravenous immunoglobulin

L. Paxton; C. Hawkins; P. Crispin

doi:10.1111/imj.13205

Selecting haematological malignancy patients for intravenous immunoglobulin

L. Paxton, C. Hawkins, P. Crispin^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Prior randomised studies of immunoglobulin replacement therapy have studied mixed populations with or without a history of infections. Immunoglobulin therapy is expensive and in limited supply suggesting that optimising patient selection is of value. In this retrospective study, infection history identified high-risk groups benefiting from treatment. A group of patients without any infection history had a low risk of infection without immunoglobulin.

Original language	English
Pages (from-to)	1216-1218
Number of pages	3
Journal	Internal Medicine Journal
Volume	46
Issue number	10
DOIs	https://doi.org/10.1111/imj.13205
Publication status	Published - 1 Oct 2016

Access to Document

10.1111/imj.13205

Cite this

@article{5f32fb8a25f743b9bcf6c844e6a41ab2,

title = "Selecting haematological malignancy patients for intravenous immunoglobulin",

abstract = "Prior randomised studies of immunoglobulin replacement therapy have studied mixed populations with or without a history of infections. Immunoglobulin therapy is expensive and in limited supply suggesting that optimising patient selection is of value. In this retrospective study, infection history identified high-risk groups benefiting from treatment. A group of patients without any infection history had a low risk of infection without immunoglobulin.",

keywords = "haematological malignancy, infection, intravenous immunoglobulin",

author = "L. Paxton and C. Hawkins and P. Crispin",

note = "Publisher Copyright: {\textcopyright} 2016 Royal Australasian College of Physicians",

year = "2016",

month = oct,

day = "1",

doi = "10.1111/imj.13205",

language = "English",

volume = "46",

pages = "1216--1218",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "John Wiley \& Sons Inc.",

number = "10",

}

TY - JOUR

T1 - Selecting haematological malignancy patients for intravenous immunoglobulin

AU - Paxton, L.

AU - Hawkins, C.

AU - Crispin, P.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Prior randomised studies of immunoglobulin replacement therapy have studied mixed populations with or without a history of infections. Immunoglobulin therapy is expensive and in limited supply suggesting that optimising patient selection is of value. In this retrospective study, infection history identified high-risk groups benefiting from treatment. A group of patients without any infection history had a low risk of infection without immunoglobulin.

AB - Prior randomised studies of immunoglobulin replacement therapy have studied mixed populations with or without a history of infections. Immunoglobulin therapy is expensive and in limited supply suggesting that optimising patient selection is of value. In this retrospective study, infection history identified high-risk groups benefiting from treatment. A group of patients without any infection history had a low risk of infection without immunoglobulin.

KW - haematological malignancy

KW - infection

KW - intravenous immunoglobulin

UR - https://www.scopus.com/pages/publications/84992029030

U2 - 10.1111/imj.13205

DO - 10.1111/imj.13205

M3 - Article

SN - 1444-0903

VL - 46

SP - 1216

EP - 1218

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 10

ER -

Selecting haematological malignancy patients for intravenous immunoglobulin

Abstract

Access to Document

Other files and links

Fingerprint

Cite this